1. Home
  2. PRLD vs BMR Comparison

PRLD vs BMR Comparison

Compare PRLD & BMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRLD
  • BMR
  • Stock Information
  • Founded
  • PRLD 2016
  • BMR 2009
  • Country
  • PRLD United States
  • BMR Israel
  • Employees
  • PRLD N/A
  • BMR N/A
  • Industry
  • PRLD Medicinal Chemicals and Botanical Products
  • BMR Computer Software: Prepackaged Software
  • Sector
  • PRLD Health Care
  • BMR Technology
  • Exchange
  • PRLD Nasdaq
  • BMR Nasdaq
  • Market Cap
  • PRLD 50.1M
  • BMR 59.3M
  • IPO Year
  • PRLD 2020
  • BMR 2023
  • Fundamental
  • Price
  • PRLD $0.78
  • BMR $2.64
  • Analyst Decision
  • PRLD Strong Buy
  • BMR
  • Analyst Count
  • PRLD 2
  • BMR 0
  • Target Price
  • PRLD $4.50
  • BMR N/A
  • AVG Volume (30 Days)
  • PRLD 110.2K
  • BMR 56.4K
  • Earning Date
  • PRLD 05-06-2025
  • BMR 05-20-2025
  • Dividend Yield
  • PRLD N/A
  • BMR N/A
  • EPS Growth
  • PRLD N/A
  • BMR N/A
  • EPS
  • PRLD N/A
  • BMR N/A
  • Revenue
  • PRLD $7,000,000.00
  • BMR $3,064,000.00
  • Revenue This Year
  • PRLD N/A
  • BMR N/A
  • Revenue Next Year
  • PRLD N/A
  • BMR N/A
  • P/E Ratio
  • PRLD N/A
  • BMR N/A
  • Revenue Growth
  • PRLD N/A
  • BMR 5.33
  • 52 Week Low
  • PRLD $0.61
  • BMR $1.86
  • 52 Week High
  • PRLD $6.80
  • BMR $6.71
  • Technical
  • Relative Strength Index (RSI)
  • PRLD 46.96
  • BMR 54.93
  • Support Level
  • PRLD $0.73
  • BMR $2.57
  • Resistance Level
  • PRLD $1.00
  • BMR $2.89
  • Average True Range (ATR)
  • PRLD 0.09
  • BMR 0.19
  • MACD
  • PRLD -0.01
  • BMR 0.04
  • Stochastic Oscillator
  • PRLD 18.96
  • BMR 68.39

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

About BMR Beamr Imaging Ltd.

Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.

Share on Social Networks: